NORTHERN TRUST CORP - KRYSTAL BIOTECH INC ownership

KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 189 filers reported holding KRYSTAL BIOTECH INC in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of KRYSTAL BIOTECH INC
ValueSharesWeighting
Q3 2023$24,738,508
+0.8%
213,263
+2.0%
0.01%0.0%
Q2 2023$24,552,331
+52.2%
209,134
+3.8%
0.01%
+66.7%
Q1 2023$16,130,248
+1.2%
201,477
+0.1%
0.00%0.0%
Q4 2022$15,946,035
+13.1%
201,288
-0.5%
0.00%0.0%
Q3 2022$14,097,000
+6.8%
202,238
+0.6%
0.00%0.0%
Q2 2022$13,201,000
+2.2%
201,058
+3.6%
0.00%
+50.0%
Q1 2022$12,915,000
+0.6%
194,102
+5.7%
0.00%0.0%
Q4 2021$12,840,000
+35.5%
183,559
+1.2%
0.00%0.0%
Q3 2021$9,473,000
-26.1%
181,434
-3.8%
0.00%0.0%
Q2 2021$12,822,000
-6.8%
188,555
+5.5%
0.00%
-33.3%
Q1 2021$13,762,000
+32.5%
178,642
+3.2%
0.00%
+50.0%
Q4 2020$10,388,000
+36.0%
173,126
-2.4%
0.00%0.0%
Q3 2020$7,639,000
+11.8%
177,424
+7.5%
0.00%0.0%
Q2 2020$6,835,000
+6.3%
165,008
+11.0%
0.00%0.0%
Q1 2020$6,427,000
-16.9%
148,639
+6.5%
0.00%0.0%
Q4 2019$7,730,000
+55.6%
139,594
-2.4%
0.00%
+100.0%
Q3 2019$4,967,000
+208.7%
143,049
+257.8%
0.00%
Q2 2019$1,609,000
+128.2%
39,984
+86.6%
0.00%
Q1 2019$705,000
+55.3%
21,424
-1.9%
0.00%
Q4 2018$454,00021,8450.00%
Other shareholders
KRYSTAL BIOTECH INC shareholders Q3 2023
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 771,250$53,949,0004.15%
First Light Asset Management, LLC 680,170$47,578,0003.41%
ACT CAPITAL MANAGEMENT, LLC 59,000$4,127,0002.98%
S Squared Technology, LLC 95,215$6,660,0002.98%
Redmile Group, LLC 1,820,898$127,372,0002.90%
Soleus Capital Management, L.P. 228,437$15,979,0001.60%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 50,922$3,562,0001.59%
Artal Group S.A. 700,000$48,965,0001.33%
SILVERARC CAPITAL MANAGEMENT, LLC 46,670$3,265,0001.32%
Kynam Capital Management, LP 34,816$2,435,0001.30%
View complete list of KRYSTAL BIOTECH INC shareholders